COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner.
Saved in:
| Title: | COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner. |
|---|---|
| Authors: | Jiang GB; Department of Oncological Surgery, Taizhou Enze Medical Center (Group) Enze Hospital, Zhejiang, China. caofl@enzemed.com., Fang HY, Tao DY, Chen XP, Cao FL |
| Source: | European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2019 May; Vol. 23 (9), pp. 3838-3846. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31115011 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jiang+GB%22">Jiang GB</searchLink>; Department of Oncological Surgery, Taizhou Enze Medical Center (Group) Enze Hospital, Zhejiang, China. caofl@enzemed.com.<br /><searchLink fieldCode="AU" term="%22Fang+HY%22">Fang HY</searchLink><br /><searchLink fieldCode="AU" term="%22Tao+DY%22">Tao DY</searchLink><br /><searchLink fieldCode="AU" term="%22Chen+XP%22">Chen XP</searchLink><br /><searchLink fieldCode="AU" term="%22Cao+FL%22">Cao FL</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229717360%22">European review for medical and pharmacological sciences</searchLink> [Eur Rev Med Pharmacol Sci] 2019 May; Vol. 23 (9), pp. 3838-3846. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Verduci%22">Verduci </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>9717360 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2284-0729 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211283602%22">11283602 </searchLink><i>NLM ISO Abbreviation: </i>Eur Rev Med Pharmacol Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31115011 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.26355/eurrev_201905_17811 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3838 Titles: – TitleFull: COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jiang GB – PersonEntity: Name: NameFull: Fang HY – PersonEntity: Name: NameFull: Tao DY – PersonEntity: Name: NameFull: Chen XP – PersonEntity: Name: NameFull: Cao FL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2019 May Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2284-0729 Numbering: – Type: volume Value: 23 – Type: issue Value: 9 Titles: – TitleFull: European review for medical and pharmacological sciences Type: main |
| ResultId | 1 |
